Although animal studies provide insights, we cannot assume the effects of Ozempic during pregnancy solely based on these findings
Wegovy has an FDA-approved indication to reduce the risk of major adverse cardiovascular events, including cardiovascular death, nonfatal heart attack, and nonfatal stroke, in adults with established cardiovascular disease and either obesity or overweight
Perez-Garcia A, Hurtado-Carneiro V, Herrero-De-Dios C, Dongil P, Garcia-Maurino JE, Sanchez MD, et al
Mild temporary symptoms may include: Redness at injection site Light nausea Slight fatigue or headache during adjustment phase Not recommended for individuals with active cancers or certain metabolic conditions our physicians will evaluate your history during consultation
* 55.8% greater LDL-C reduction versus placebo at 24 weeks
All patients were required to have baseline HbA1c of 7.0% (indicative of uncontrolled hyperglycemia) in AEMR on the index date or closest available date (between 180 days pre index to 30 days post index)